Zobrazeno 1 - 10
of 15
pro vyhledávání: '"John Hackman"'
Autor:
Christian Jackisch, Christophe Lecocq, Serena Di Cosimo, Frances M. Boyle, José Baselga, Michael Untch, Ian E. Smith, Eileen Holmes, Hans Wildiers, Debora Fumagalli, Martine Piccart-Gebhart, Jens Huober, Hryhoriy Adamchuk, Lorena de la Peña, Richard D. Gelber, Tamas Hickish, John Hackman, Binghe Xu, Evandro de Azambuja, Eva Ciruelos, Juan Carlos Toral Pena, Severine Sarp, Lokanatha Dasappa, István Láng, Christelle Jouannaud
Publikováno v:
European journal of cancer (Oxford, England : 1990). 118
BACKGROUND: Lapatinib (L) plus trastuzumab (T) with weekly paclitaxel significantly increased the pathologic complete response (pCR) rate compared with the anti-human epidermal growth factor receptor 2 (HER2) agent alone plus paclitaxel. The event-fr
Autor:
Cornelia Kolberg-Liedtke, Friedrich Feuerhake, Madlen Garke, Matthias Christgen, Ronald Kates, Eva Maria Grischke, Helmut Forstbauer, Michael Braun, Mathias Warm, John Hackmann, Christoph Uleer, Bahriye Aktas, Claudia Schumacher, Sherko Kuemmel, Rachel Wuerstlein, Monika Graeser, Ulrike Nitz, Hans Kreipe, Oleg Gluz, Nadia Harbeck
Publikováno v:
Breast Cancer Research, Vol 24, Iss 1, Pp 1-13 (2022)
Abstract Background Higher density of stromal tumor-infiltrating lymphocytes (sTILs) at baseline has been associated with increased rates of pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (
Externí odkaz:
https://doaj.org/article/8e767ca38fb44eb2b85c5566cfa49c03
Autor:
J. May, John Hackman, R. P. Steffen, John H. Suh, T. Pinter, Baldassarre Stea, M. Craig, Edward G. Shaw
Publikováno v:
British Journal of Cancer
Efaproxiral (Efaproxyn, RSR13), a synthetic allosteric modifier of haemoglobin (Hb), decreases Hb-oxygen (O(2)) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy. This analysis evaluated the Phase 3, Radiation Enha
Autor:
John H. Suh, Andrew Pearlman, Minesh P. Mehta, Walter J. Curran, Baldassarre Stea, John Hackman, Kevin Murray, Michael Gerber, Sidney Kadish, Laurie E. Gaspar, Charles B. Scott, Edward G. Shaw
Publikováno v:
Journal of Clinical Oncology. 21:2364-2371
Purpose: This phase II, open-label, multicenter study assessed the efficacy and safety of the potential radiation enhancer RSR13 plus cranial radiation therapy (RT) in patients with brain metastases. The primary end point was patient survival in comp
Autor:
GEOFFREY SCAMMELL, JOHN HACKMAN, GLENN BURGESS, D. J. LYON, DAVID J. STARKEY, GLORIA CLIFTON, LEO M. AKVELD, N. A.M. RODGER, ALAN G. JAMIESON, TOM POCOCK, COLIN WHITE, PHILIP MACDOUGALL, WILLIAM HENRY FLAYHART, BENJAMIN A.G. FULLER, JAMES COULL, J. TH. THOR, JAY C. MARTIN, ANDREW LAMBERT, R. O. MORRIS, JAMES GOLDRICK, DAVID HOBBS, A. B. SAINSBURY, GEOFFREY TILL, JOHN KINROSS, K. D. McBRIDE
Publikováno v:
The Mariner's Mirror. 83:350-377
Publikováno v:
American journal of clinical oncology. 30(6)
To determine whether efaproxiral, an allosteric modifier of hemoglobin, improves quality of life and quality of survival in patients with primary breast cancer and brain metastases when used as an adjunct to whole-brain radiation therapy (WBRT).Patie
Autor:
John Hackman
Publikováno v:
International Journal of Maritime History. 9:216-218
Autor:
John Hackman
Publikováno v:
International Journal of Maritime History. 20:409-410
Autor:
John Hackman
Publikováno v:
International Journal of Maritime History. 18:532-533
Autor:
John Hackman
Publikováno v:
International Journal of Maritime History. 16:355-356